Endo International PLC ENDO INTER.../  IE00BJ3V9050  /

London Domestic
9/30/2022  4:43:07 PM Chg. -0.0048 Volume Bid6:00:11 AM Ask6:00:11 AM Market Capitalization Dividend Y. P/E Ratio
0.0952USD -4.80% 8,887
Turnover: 850.0424
-Bid Size: - -Ask Size: - 67.46 mill.USD 0.00% -

Business description

Endo International plc is a global specialty pharmaceutical company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets and distributes quality branded pharmaceutical and generic pharmaceutical products as well as over-the-counter medications though its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA.
 

Management board & Supervisory board

CEO
Blaise Coleman
Management board
Mark Bradley, Dr. James P. Tursi, George Apostol, M.D., James Papp, Joseph A. Barbarite, Laure Park, Matthew J. Maletta, Patrick Barry, Robert Polke, Ruth Thorpe, Susan Williamson, Tracy Basso
Supervisory board
Mark G. Barberio, Blaise Coleman, Dr. M. Christine Smith, Dr. Nancy J. Hutson, Jennifer M. Chao, Michael Hyatt, Shane M. Cooke, William P. Montague
 

Company data

Name: Endo International Plc.
Address: First Floor, Minerva House, Simmonscourt Road,Ballsbridge, Dublin 4, Ireland
Phone: +11-353-1-268-200
Fax: -
E-mail: -
Internet: www.endo.com/
Industry: Healthcare
Sector: Pharmaceutical Industry
Sub sector: Pharmaceuticals
End of financial year: 12/31
Free Float: 57.10%
IPO date: -

Investor relations

Name: -
IR phone: +1-845-364-4833
IR Fax: -
IR e-mail: Relations.Investor@endo.com

Main Shareholders

Freefloat
 
57.10%
BlackRock Inc.
 
15.70%
The Vanguard Group, Inc.
 
10.90%
Renaissance Technologies LLC
 
8.40%
Paulson & Co., Inc.
 
7.90%